Lindbrook Capital, LLC Eli Lilly & CO Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lindbrook Capital, LLC holds 6,849 shares of LLY stock, worth $5.44 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

6,849

Previous 6,686 2.44%

Holding current value

$5.44 Million

Previous $6.05 Million 0.23%

% of portfolio

0.51%

Previous 0.57%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $125,858 - $156,483	163 Added 2.44%	6,849 $6.07 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $284,149 - $356,343	392 Added 6.23%	6,686 $6.05 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $80,539 - $107,750	136 Added 2.21%	6,294 $4.9 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $307,236 - $362,191	585 Added 10.5%	6,158 $3.59 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $134,757 - $185,783	310 Added 5.89%	5,573 $2.99 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $89,087 - $119,120	254 Added 5.07%	5,263 $2.47 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $53,117 - $62,384	-171 Reduced 3.3%	5,009 $1.72 Million
Q4 2022 Jan 24, 2023	BUY	$321.55 - $374.67 $27,331 - $31,846	85 Added 1.67%	5,180 $0
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $91,019 - $103,726	307 Added 6.41%	5,095 $1.65 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $988,934 - $1.16 Million	3,548 Added 286.13%	4,788 $1.55 Million
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $26,519 - $32,957	113 Added 10.03%	1,240 $355,000
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $7,312 - $8,999	33 Added 3.02%	1,127 $260,000
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $100,566 - $130,081	-557 Reduced 33.74%	1,094 $251,000
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $28,920 - $37,438	176 Added 11.93%	1,651 $308,000
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $5,870 - $7,768	-45 Reduced 2.96%	1,475 $249,000
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $24,126 - $27,906	165 Added 12.18%	1,520 $225,000
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $13,914 - $16,746	102 Added 8.14%	1,355 $222,000
Q1 2020 Apr 22, 2020	SELL	$119.05 - $147.35 $31,310 - $38,753	-263 Reduced 17.35%	1,253 $174,000
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $534 - $662	-5 Reduced 0.33%	1,516 $199,000
Q3 2019 Oct 31, 2019	BUY	$106.79 - $116.16 $7,261 - $7,898	68 Added 4.68%	1,521 $170,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $30,799 - $35,950	-278 Reduced 16.06%	1,453 $160,000
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $92,053 - $108,353	827 Added 91.48%	1,731 $224,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $95,733 - $107,250	904 New	904 $104,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Eli Lilly & CO Transaction History